Innovid (NYSE:CTV – Free Report) had its price objective hoisted by Morgan Stanley from $1.40 to $1.50 in a research note released on Thursday morning, Benzinga reports. Morgan Stanley currently has an equal weight rating on the stock. Separately, Needham & Company LLC reduced their target price on shares of Innovid from $3.00 to $1.50 […]